Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pfizer Oy
OY
Active
Y-tunnus 0194053-9
Tietokuja 4, 00330
Helsinki
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1959 · 67 years old
84 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pfizer Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
325M
244M
163M
81M
0M
2021: 175M
175M
2021
2022: 261M (+49% vs 2021)
261M
+49%
2022
2023: 90M (-66% vs 2022)
90M
-66%
2023
2024: 92M (+2% vs 2023)
92M
+2%
2024
2025: 80M (-13% vs 2024)
80M
-13%
2025
EBITDA
EUR millions
16M
12M
8M
4M
0M
2021: 11M
11M
2021
2022: 13M (+18% vs 2021)
13M
+18%
2022
2023: 5M (-62% vs 2022)
5M
-62%
2023
2024: 7M (+40% vs 2023)
7M
+40%
2024
2025: 5M (-29% vs 2024)
5M
-29%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
80 269
91 518
90 072
260 602
174 765
Staff expenses
−13 589
−16 698
−14 809
−15 663
−14 024
EBITDA
4 603
7 118
4 807
12 882
10 810
Depreciation & amort.
−1 298
−1 337
−1 347
−1 205
−978
EBIT
3 305
5 781
3 460
11 677
9 832
Net financials
106
331
107
−298
434
Profit before tax
3 411
6 112
3 567
11 379
10 266
Tax
733
1 167
622
2 595
2 155
Net profit
2 652
4 415
2 842
8 783
8 111
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
63 847
64 554
81 267
77 199
74 077
Equity
31 520
28 868
24 452
21 610
20 827
Long-term debt
0
0
0
—
—
Short-term debt
33 799
10 740
26 211
55 589
53 018
Total debt
32 327
35 686
56 815
55 589
53 250
Financial ratios
5-year trend
EBITDA margin
5,7 %
This company
15,8 %
Market median
This company
Market median
64% below market
2021
2025
Equity ratio
49,4 %
This company
38,2 %
Market median
This company
Market median
29% above market
2021
2025
Return on equity
8,4 %
This company
18,4 %
Market median
This company
Market median
54% below market
2021
2025
Net profit margin
3,3 %
This company
8,1 %
Market median
This company
Market median
59% below market
2021
2025
Asset turnover
1,26×
This company
1,12×
Market median
This company
Market median
12% above market
2021
2025
Debt / equity
1,03×
This company
0,62×
Market median
This company
Market median
66% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
View
PDF
More on Pfizer Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
